About
A specialty insurance practice for life-sciences operators. Texas-led, with national specialty reach.
Life Sciences Liability is a specialty insurance platform built for the operators who actually sign sponsor MSAs, GPO supplier agreements, PBM credentialing packets, hospital purchase contracts, clinical trial agreements, and 503B outsourcing agreements. The platform exists to translate the insurance language inside those contracts into plain English, identify where an operator\'s current program does and does not satisfy the requirements, and rebuild programs to satisfy them when necessary.
Practice methodology
How we work.
The practice starts at the contract. Sponsor MSAs, hospital purchase contracts, GPO supplier agreements, and other commercial agreements contain detailed insurance schedules — required coverages, limits, endorsements, form requirements, indemnity language, and survival provisions. Each of these clauses has a specific operational and financial consequence, and the most common insurance failures we see are not gaps in coverage philosophy but gaps in alignment between the contract and the operator\'s actual program.
The platform translates each clause into plain English (the public clause glossary at /glossary contains the current library), scores an operator\'s program against the clause requirements (the Free Insurance Requirements Analyzer at /#analyzer is the public-facing version of this workflow), and produces a clause-by-clause review identifying where the program meets, partially meets, or falls short of contract requirements.
Where the review identifies gaps, the practice works with operators to rebuild programs through the specialty life-sciences insurance markets that have the appetite, the form depth, and the carrier ratings necessary to satisfy sponsor and hospital contract requirements. The practice is agency-neutral and does not name specific carriers on the public site.
Editorial standards
How content on this site is produced and maintained.
Content on lifesciencesliability.com is written for operators — CFOs, COOs, General Counsels, Quality and Regulatory leads — who are reading sponsor contracts, FDA registrations, hospital purchase contracts, and PBM credentialing packets and trying to figure out which insurance program structure actually satisfies them. The voice is intentionally direct and avoids the marketing tone common to generic agency websites.
Q&A pages cite primary regulatory and standards-body sources where available — FDA guidance, 21 CFR (Code of Federal Regulations), USP general chapters, HHS HIPAA materials, SEC and DOL frameworks, and state statutes. Citations are direct links to the authoritative source rather than to secondary commentary.
Premium ranges and cost estimates are directional rather than quotes. Real underwriting depends on the specific operator\'s claims history, facility profile, product mix, sponsor and hospital contract obligations, jurisdictional exposure, and the specific markets underwriting the program. Variation of 50% above or below quoted ranges is not uncommon for operators with unusual risk profiles.
Pages are dated with a visible "Last updated" timestamp. Material regulatory changes (e.g., FDA LDT rule status, USP 797/800 revisions, FDA compounding enforcement actions) trigger content review and update.
Sub-verticals served
Eight sub-verticals with distinct program shapes.
The practice serves pharmaceutical and medical device contract manufacturers, contract research organizations, Class I/II/III medical device manufacturers, clinical-stage biotech and drug companies, 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, GLP-1 compounding operators, and CLIA clinical and molecular diagnostic labs.
Each sub-vertical has a distinct program shape. The practice does not treat life-sciences insurance as a single coverage category; the underwriting markets, carrier appetite, contract obligations, and compliance frameworks vary materially across sub-verticals and are addressed accordingly.
Geographic scope
Texas-led, national specialty reach.
The practice is headquartered in Texas and primarily serves Texas-based life-sciences operators, with specialty programs placed across the major US life-sciences clusters — California, Massachusetts, New Jersey, New York, Florida, North Carolina, Pennsylvania, Illinois, and others. State-specific landing pages address the cluster characteristics, regulatory context, and market commentary relevant to each major life-sciences state.
See state-specific commentary for Texas, California, Massachusetts, New Jersey, New York, Florida, and North Carolina.
Carrier and form posture
Agency-neutral on the public site.
The site does not name specific carriers in editorial content. This reflects both Texas Department of Insurance advertising-rule alignment and the agency-neutral positioning of the practice — the right carrier for a given program depends on the operator\'s specific risk profile, claims history, sub-vertical, sponsor obligations, and program structure. Generalist commercial markets are rarely the right fit for serious life-sciences risk; the specialty life-sciences markets are typically where compliant programs get built.
Information on this site is educational and does not constitute legal, regulatory, or insurance advice. Coverage availability and pricing vary by carrier, state, operator size, product mix, and risk profile.
Free coverage review